eThe committee convene twice a year to discuss the business of the MSG, with a primary focus on proposing and establishing high quality scientific meetings for our members.
The MSG Committee, Burlington House, March 2010.
(Left to right: John Chalmers, Steven Coombes, Ben Bardsley, Howell Edwards & David Andrews)
Steve is an NMR Spectroscopist at AstraZeneca in Macclesfield. His interests include small molecule structure elucidation, reaction monitoring and the development and implementation of software solutions for data processing. He was previously employed at Pfizer until 2008 working in the Analytical R&D group. Steve completed his 1st degree and PhD at the University of Bradford, studying natural product isolation and synthesis. Steve has been on the RSC MSG committee since 2006 and took over as Chairman in March 2010.
Prof. C. L. Paul Thomas gained his PhD at UMIST, in 1988. He was an endowed lecturer at UMIST and developed the VOC group within the Department of Instrumentation and Analytical Science. He is also a past president of the International Society of Ion Mobility Spectrometry, and has served on the editorial boards of the RSC’s Analyst and Springer’s International Journal of Ion mobility Spectrometry. His research has been dedicated to the study of VOC measurement in all its forms and in particular to biogenic VOC in humans, and he is currently the Head of the Department of Chemistry at Loughborough University, UK.
Secretary & Vice Chairman
Ben BardsleyBen is an NMR spectroscopist working in the pharmaceutical industry for GlaxoSmithKline in Stevenage. He also has experience in vibrational spectroscopy and is part of a team which provides structure elucidation and spectroscopic skills to problem solving in drug development. Ben completed his first degree in Natural Sciences and a PhD in the field of molecular recognition at Christ's College, University of Cambridge. Ben has been a member of the RSC MSG Committee since 2007 and took over as Honorary Secretary in 2009.
Howell Edwards is a Raman spectroscopist , Emeritus Professor of Molecular Spectroscopy at the University of Bradford and former Head of Chemical and Forensic Sciences there . He is interested in the applications of analytical Raman spectroscopy to forensic archaeology and art,geoscience, pharmaceuticals, drugs and contraband materials in a forensic context. He established the Centre for Astrobiology and Extremophiles Research and leads the international Science Support Team on the ESA ExoMars Raman Laser Spectrometer project , based in the UK at the University of Leicester, Space Research Centre ,to place a miniaturised Raman spectrometer for the remote detection of spectroscopic biogeological life signatures on the surface of Mars.
John studied for a BSc in Chemistry and a PhD in Vibrational Spectroscopy at the University of East Anglia. He worked for Mattson Instruments in sales and marketing of FTIR and FT-Raman spectrometers. When Mattson acquired Pye Unicam he became Business Manager for Infrared Spectroscopy for the combined group. In 1995 he founded Clairet Scientific Ltd. Clairet specialises in the application of spectroscopy to on-line, at-line measurements and in process research. The company has pioneered the development of Process Analytical Technology (PAT) in the UK and beyond. John works with FTIR, FT-NIR, Diode Array NIR, UV-visible, Raman, Terahertz, Mass and Ion mobility spectroscopy.
Committee MemberPeter Hamilton
Peter is a new member of the RSC MSG committee joining in
April 2015. He studied for an MSci in Forensic and Analytical Chemistry before a PhD
focused on the application of spectroscopic
process analytical technology to improve understanding in Pharmaceutical drying processes – both at The University of Strathclyde, Glasgow. He
then completed a collaborative post-doctoral research position with Strathclyde
and GSK in the USA before joining GSK on a full time basis in the UK. He has
experience in the use of Raman, NIR, MIR, and UV-Vis spectroscopies and their
applications in both drug substance and drug product pharmaceutical production.